HOW SMALL DO TESTICLES GET ON TRT?

Testosterone replacement therapy is commonly prescribed to treat symptoms of low testosterone such as fatigue, reduced libido, low mood and loss of muscle mass. While many men experience clear improvements in how they feel, a frequent concern before starting treatment is whether TRT causes the testicles to shrink and, if so, how noticeable those changes might be.

Understanding why testicular size can change on testosterone therapy helps explain what is normal, what is reversible, and when changes are unlikely to cause any health problems. For most men, this effect is far less dramatic than often suggested online.

Under normal conditions, the testicles produce testosterone and sperm. This process is regulated by the pituitary gland in the brain, which releases luteinising hormone and follicle stimulating hormone. These hormones signal the testicles to stay active.

When testosterone is introduced from an external source through TRT, the body senses that circulating testosterone levels are adequate. As a result, the pituitary gland reduces its release of luteinising hormone and follicle stimulating hormone. With less stimulation, the testicles reduce their activity.

This reduced hormonal signalling can lead to a decrease in sperm production and, in some men, a reduction in testicular size. TRT does not damage the testicles. Instead, it temporarily changes how active they are while external testosterone is present.

In men with underlying hypogonadism, testicles may already be slightly smaller before treatment begins.

Not all men experience noticeable changes in testicular size when using testosterone replacement therapy. Clinical experience suggests that around half of men on TRT experience some degree of reduction in testicular volume.

For many, this change is minimal and only detectable through ultrasound measurement rather than being obvious day to day. Others may notice a small visible change, while some men experience no change at all.

The likelihood of testicular shrinkage varies between individuals and may be influenced by testosterone dose, treatment duration, and method of administration. Men using higher doses outside of medical supervision are more likely to experience noticeable changes.

When testicular shrinkage does occur, it is usually mild. On average, the reduction in testicular volume is around 3 millilitres.

Changes tend to develop gradually rather than suddenly and usually occur within the first six months of starting treatment. After this initial period, further reduction is uncommon.

Most men who experience shrinkage describe it as slight rather than significant. In many cases, it does not affect appearance or cause concern once expectations are properly understood.

From a medical perspective, testicular shrinkage associated with TRT is not harmful. Testosterone replacement provides the body with sufficient testosterone, meaning overall hormone levels remain appropriate despite reduced testicular activity.

Testicular size does not influence libido, erectile function, energy levels, mood or physical performance while on TRT. These effects are driven by circulating testosterone, which is maintained through treatment.

For most men, any change in testicular size is a cosmetic issue rather than a medical problem.

Testicular size is closely linked to sperm production. Reduced luteinising hormone and follicle stimulating hormone levels during TRT can lead to reduced or absent sperm production.

Around 60 to 70 percent of men on TRT experience a reduction in sperm count, and in some cases sperm production may stop temporarily. TRT should not be relied upon as contraception.

The majority of men recover sperm production within six to twelve months of stopping testosterone therapy. Men who wish to preserve fertility should discuss this with a clinician before starting treatment.

In most cases, testicular shrinkage related to TRT is reversible. When testosterone therapy is stopped, the pituitary gland resumes production of luteinising hormone and follicle stimulating hormone, allowing the testicles to become active again.

Recovery of testicular size usually occurs gradually over several months. The speed of recovery depends on factors such as age, baseline testicular function, and length of time on treatment.

For most men, testicular shrinkage does not require treatment. However, in certain situations, additional therapies may be considered.

Medications such as clomiphene, tamoxifen, human chorionic gonadotropin, or anastrozole may be used to support testicular stimulation and sperm production in men with fertility concerns. These treatments are not routinely required and should only be used under medical supervision.

Different testosterone delivery methods may influence the likelihood of testicular shrinkage. Some evidence suggests injectable testosterone may be more suppressive than topical gels, although individual response varies.

Keeping testosterone levels within the appropriate clinical range under supervision is the most important factor in minimising unwanted effects.

Younger men and those planning to have children should discuss potential fertility effects before starting TRT. Psychological or body image concerns should also be addressed openly with a clinician.

Testicular size does not affect masculinity, sexual performance, or treatment effectiveness.

Any concerns about fertility, testicular changes, or side effects should be discussed during routine follow up appointments. Regular monitoring ensures treatment remains safe and effective.

Testicular shrinkage can occur on testosterone replacement therapy due to reduced hormonal stimulation. Many men do not notice any change, and when shrinkage does occur it is usually mild, gradual and reversible.

Changes in testicular size do not affect sexual function, masculinity or overall health. With proper medical supervision, TRT remains a safe and effective treatment for men with confirmed testosterone deficiency.